Federal regulators emphasized that the vaccine's benefits still outweighed the risk of catching the neurological disease. (Photo: RF._.studio / Pexels)…
Although the alpha variant remains the most dominant variant in Canada, delta's growth has accelerated, with the number of cases…
The committee's guidance update is also motivated by the increasing availability of Pfizer and Moderna and the risk of vaccine-induced…
The study conducted by three teams of experts found "there is a probable link between receiving the second dose (of…
How long will the vaccine protect against emerging variants of the virus. Will a booster shot be required, or will…
Health authorities maintain that the benefits continue to outweigh any risk but recommended health professionals and recipients of the vaccine…
"I would gladly test our vaccine head-to-head against any out there. It is always difficult to compare preclinical results, however,…
Late-stage Phase II/III trials are currently underway in the UK, Brazil and South Africa and are due to start in…
It is likely we’ll eventually have a coronavirus vaccine — but perhaps not as quickly as some expect. From development,…
This website uses cookies.